Impact of SARS-CoV-2 infection history on the clinical features and outcomes of patients with recurrent pulmonary tuberculosis: a retrospective case–control study
Wei Tang, Ke Mi, Haiyan Xue, Yating Liang, Haiming Zhang, Lei Xu, Sha Lin, Yunzhu Long, Zhixiong Fang · 2026
Read Impact of SARS-CoV-2 infection history on the clinical features and outcomes of patients with recurrent pulmonary tuberculosis: a retrospective case–control study by Wei Tang, Ke Mi, Haiyan Xue, Yating Liang, Haiming Zhang, Lei Xu, Sha Lin, Yunzhu Long, Zhixiong Fang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13250866.txt.
Description
Tang and co-authors ask whether a past COVID-19 infection changes the course of tuberculosis that returns after earlier treatment. Their 2026 Annals of Medicine study covers three hundred fifty-five patients with recurrent lung tuberculosis treated between 2019 and 2025. About one hundred forty of them had confirmed prior COVID-19.
After matching similar patients, the prior-COVID group needed invasive procedures more often, yet their lung images cleared somewhat faster. A breathlessness difference faded once multiple testing was accounted for. Final treatment success did not differ between the groups, and past COVID was not an independent risk factor for poor results. Drug resistance and disease outside the lungs were the real danger signs, though the authors advise closer monitoring.
Catalog record
| CREATOR | Wei Tang, Ke Mi, Haiyan Xue, Yating Liang, Haiming Zhang, Lei Xu, Sha Lin, Yunzhu Long, Zhixiong Fang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |